China Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
China Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
Abstract
Summary
Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Chinese biotechnology market had total revenues of $39.0 billion in 2021, representing a compound annual growth rate (CAGR) of 16.8% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $20.5 billion, equivalent to 52.6% of the market's overall value.
- Many multinational biotechnology companies have signed contracts to have new drugs developed in China and this is spurring growth.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts
Reasons to Buy
- What was the size of the China biotechnology market by value in 2021?
- What will be the size of the China biotechnology market in 2026?
- What factors are affecting the strength of competition in the China biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in China's biotechnology market?
Content
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
8 Company Profiles
8.1. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
8.2. Shanghai Kehua Bio-engineering Co Ltd
8.3. Novo Nordisk A/S
8.4. Sinovac Biotech Ltd.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: China biotechnology industry value: $ billion, 2016–21
Table 2: China biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: China biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: China biotechnology industry geography segmentation: $ billion, 2021
Table 5: China biotechnology industry value forecast: $ billion, 2021–26
Table 6: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts
Table 7: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios
Table 8: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Key Employees
Table 9: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 10: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 11: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 12: Novo Nordisk A/S: key facts
Table 13: Novo Nordisk A/S: Annual Financial Ratios
Table 14: Novo Nordisk A/S: Key Employees
Table 15: Novo Nordisk A/S: Key Employees Continued
Table 16: Sinovac Biotech Ltd.: key facts
Table 17: Sinovac Biotech Ltd.: Annual Financial Ratios
Table 18: Sinovac Biotech Ltd.: Key Employees
Table 19: China size of population (million), 2017–21
Table 20: China gdp (constant 2005 prices, $ billion), 2017–21
Table 21: China gdp (current prices, $ billion), 2017–21
Table 22: China inflation, 2017–21
Table 23: China consumer price index (absolute), 2017–21
Table 24: China exchange rate, 2017–21
List of Figures
Figure 1: China biotechnology industry value: $ billion, 2016–21
Figure 2: China biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: China biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: China biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in China, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in China, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in China, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2021
Summary
Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Chinese biotechnology market had total revenues of $39.0 billion in 2021, representing a compound annual growth rate (CAGR) of 16.8% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $20.5 billion, equivalent to 52.6% of the market's overall value.
- Many multinational biotechnology companies have signed contracts to have new drugs developed in China and this is spurring growth.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts
Reasons to Buy
- What was the size of the China biotechnology market by value in 2021?
- What will be the size of the China biotechnology market in 2026?
- What factors are affecting the strength of competition in the China biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in China's biotechnology market?
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
8 Company Profiles
8.1. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
8.2. Shanghai Kehua Bio-engineering Co Ltd
8.3. Novo Nordisk A/S
8.4. Sinovac Biotech Ltd.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: China biotechnology industry value: $ billion, 2016–21
Table 2: China biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: China biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: China biotechnology industry geography segmentation: $ billion, 2021
Table 5: China biotechnology industry value forecast: $ billion, 2021–26
Table 6: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts
Table 7: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios
Table 8: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Key Employees
Table 9: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 10: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 11: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 12: Novo Nordisk A/S: key facts
Table 13: Novo Nordisk A/S: Annual Financial Ratios
Table 14: Novo Nordisk A/S: Key Employees
Table 15: Novo Nordisk A/S: Key Employees Continued
Table 16: Sinovac Biotech Ltd.: key facts
Table 17: Sinovac Biotech Ltd.: Annual Financial Ratios
Table 18: Sinovac Biotech Ltd.: Key Employees
Table 19: China size of population (million), 2017–21
Table 20: China gdp (constant 2005 prices, $ billion), 2017–21
Table 21: China gdp (current prices, $ billion), 2017–21
Table 22: China inflation, 2017–21
Table 23: China consumer price index (absolute), 2017–21
Table 24: China exchange rate, 2017–21
List of Figures
Figure 1: China biotechnology industry value: $ billion, 2016–21
Figure 2: China biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: China biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: China biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in China, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in China, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in China, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2021
Related Report
